151 related articles for article (PubMed ID: 11402400)
21. Generation and Genetic Correction of USH2A c.2299delG Mutation in Patient-Derived Induced Pluripotent Stem Cells.
Liu X; Lillywhite J; Zhu W; Huang Z; Clark AM; Gosstola N; Maguire CT; Dykxhoorn D; Chen ZY; Yang J
Genes (Basel); 2021 May; 12(6):. PubMed ID: 34070435
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive screening of the USH2A gene in Usher syndrome type II and non-syndromic recessive retinitis pigmentosa.
Seyedahmadi BJ; Rivolta C; Keene JA; Berson EL; Dryja TP
Exp Eye Res; 2004 Aug; 79(2):167-73. PubMed ID: 15325563
[TBL] [Abstract][Full Text] [Related]
23. A novel gene for Usher syndrome type 2: mutations in the long isoform of whirlin are associated with retinitis pigmentosa and sensorineural hearing loss.
Ebermann I; Scholl HP; Charbel Issa P; Becirovic E; Lamprecht J; Jurklies B; Millán JM; Aller E; Mitter D; Bolz H
Hum Genet; 2007 Apr; 121(2):203-11. PubMed ID: 17171570
[TBL] [Abstract][Full Text] [Related]
24. Three novel mutations and twelve polymorphisms identified in the USH2A gene in Israeli USH2 families.
Adato A; Weston MD; Berry A; Kimberling WJ; Bonne-Tamir A
Hum Mutat; 2000 Apr; 15(4):388. PubMed ID: 10738000
[TBL] [Abstract][Full Text] [Related]
25. The Usher syndrome in the Lebanese population and further refinement of the USH2A candidate region.
Saouda M; Mansour A; Bou Moglabey Y; El Zir E; Mustapha M; Chaib H; Nehmé A; Mégarbané A; Loiselet J; Petit C; Slim R
Hum Genet; 1998 Aug; 103(2):193-8. PubMed ID: 9760205
[TBL] [Abstract][Full Text] [Related]
26. Novel mutations in MYO7A and USH2A in Usher syndrome.
Maubaret C; Griffoin JM; Arnaud B; Hamel C
Ophthalmic Genet; 2005 Mar; 26(1):25-9. PubMed ID: 15823922
[TBL] [Abstract][Full Text] [Related]
27. Identification of 51 novel exons of the Usher syndrome type 2A (USH2A) gene that encode multiple conserved functional domains and that are mutated in patients with Usher syndrome type II.
van Wijk E; Pennings RJ; te Brinke H; Claassen A; Yntema HG; Hoefsloot LH; Cremers FP; Cremers CW; Kremer H
Am J Hum Genet; 2004 Apr; 74(4):738-44. PubMed ID: 15015129
[TBL] [Abstract][Full Text] [Related]
28. Clinical aspects of Usher syndrome and the USH2A gene in a cohort of 433 patients.
Blanco-Kelly F; Jaijo T; Aller E; Avila-Fernandez A; López-Molina MI; Giménez A; García-Sandoval B; Millán JM; Ayuso C
JAMA Ophthalmol; 2015 Feb; 133(2):157-64. PubMed ID: 25375654
[TBL] [Abstract][Full Text] [Related]
29. A mutation (2314delG) in the Usher syndrome type IIA gene: high prevalence and phenotypic variation.
Liu XZ; Hope C; Liang CY; Zou JM; Xu LR; Cole T; Mueller RF; Bundey S; Nance W; Steel KP; Brown SD
Am J Hum Genet; 1999 Apr; 64(4):1221-5. PubMed ID: 10090909
[No Abstract] [Full Text] [Related]
30. Novel deletions involving the USH2A gene in patients with Usher syndrome and retinitis pigmentosa.
García-García G; Aller E; Jaijo T; Aparisi MJ; Larrieu L; Faugère V; Blanco-Kelly F; Ayuso C; Roux AF; Millán JM
Mol Vis; 2014; 20():1398-410. PubMed ID: 25352746
[TBL] [Abstract][Full Text] [Related]
31. Identification of three novel mutations in the USH1C gene and detection of thirty-one polymorphisms used for haplotype analysis.
Zwaenepoel I; Verpy E; Blanchard S; Meins M; Apfelstedt-Sylla E; Gal A; Petit C
Hum Mutat; 2001; 17(1):34-41. PubMed ID: 11139240
[TBL] [Abstract][Full Text] [Related]
32. Usher syndrome type 2 caused by activation of an USH2A pseudoexon: implications for diagnosis and therapy.
Vaché C; Besnard T; le Berre P; García-García G; Baux D; Larrieu L; Abadie C; Blanchet C; Bolz HJ; Millan J; Hamel C; Malcolm S; Claustres M; Roux AF
Hum Mutat; 2012 Jan; 33(1):104-8. PubMed ID: 22009552
[TBL] [Abstract][Full Text] [Related]
33. Molecular Inversion Probe-Based Sequencing of
Reurink J; Dockery A; Oziębło D; Farrar GJ; Ołdak M; Ten Brink JB; Bergen AA; Rinne T; Yntema HG; Pennings RJE; van den Born LI; Aben M; Oostrik J; Venselaar H; Plomp AS; Khan MI; van Wijk E; Cremers FPM; Roosing S; Kremer H
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203967
[TBL] [Abstract][Full Text] [Related]
34. Novel USH2A mutations in Israeli patients with retinitis pigmentosa and Usher syndrome type 2.
Kaiserman N; Obolensky A; Banin E; Sharon D
Arch Ophthalmol; 2007 Feb; 125(2):219-24. PubMed ID: 17296898
[TBL] [Abstract][Full Text] [Related]
35. Visual Outcomes in Japanese Patients with Retinitis Pigmentosa and Usher Syndrome Caused by USH2A Mutations.
Nagase Y; Kurata K; Hosono K; Suto K; Hikoya A; Nakanishi H; Mizuta K; Mineta H; Minoshima S; Hotta Y
Semin Ophthalmol; 2018; 33(4):560-565. PubMed ID: 28678594
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive molecular diagnosis of a large cohort of Japanese retinitis pigmentosa and Usher syndrome patients by next-generation sequencing.
Oishi M; Oishi A; Gotoh N; Ogino K; Higasa K; Iida K; Makiyama Y; Morooka S; Matsuda F; Yoshimura N
Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7369-75. PubMed ID: 25324289
[TBL] [Abstract][Full Text] [Related]
37. Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations.
Dulla K; Slijkerman R; van Diepen HC; Albert S; Dona M; Beumer W; Turunen JJ; Chan HL; Schulkens IA; Vorthoren L; den Besten C; Buil L; Schmidt I; Miao J; Venselaar H; Zang J; Neuhauss SCF; Peters T; Broekman S; Pennings R; Kremer H; Platenburg G; Adamson P; de Vrieze E; van Wijk E
Mol Ther; 2021 Aug; 29(8):2441-2455. PubMed ID: 33895329
[TBL] [Abstract][Full Text] [Related]
38. Identification of 14 novel mutations in the long isoform of USH2A in Spanish patients with Usher syndrome type II.
Aller E; Jaijo T; Beneyto M; Nájera C; Oltra S; Ayuso C; Baiget M; Carballo M; Antiñolo G; Valverde D; Moreno F; Vilela C; Collado D; Pérez-Garrigues H; Navea A; Millán JM
J Med Genet; 2006 Nov; 43(11):e55. PubMed ID: 17085681
[TBL] [Abstract][Full Text] [Related]
39. Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIa.
Eudy JD; Weston MD; Yao S; Hoover DM; Rehm HL; Ma-Edmonds M; Yan D; Ahmad I; Cheng JJ; Ayuso C; Cremers C; Davenport S; Moller C; Talmadge CB; Beisel KW; Tamayo M; Morton CC; Swaroop A; Kimberling WJ; Sumegi J
Science; 1998 Jun; 280(5370):1753-7. PubMed ID: 9624053
[TBL] [Abstract][Full Text] [Related]
40. Four USH2A founder mutations underlie the majority of Usher syndrome type 2 cases among non-Ashkenazi Jews.
Auslender N; Bandah D; Rizel L; Behar DM; Shohat M; Banin E; Allon-Shalev S; Sharony R; Sharon D; Ben-Yosef T
Genet Test; 2008 Jun; 12(2):289-94. PubMed ID: 18452394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
